New hope for advanced lung cancer: chemo-radiation combo enters trial
NCT ID NCT07547332
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests a combination of nab-paclitaxel (a chemotherapy drug) and local radiation therapy for people with extensive-stage small-cell lung cancer whose disease has worsened after initial treatment. The study aims to see if this combo can improve progression-free survival and overall survival. About 84 participants will receive up to 6 cycles of nab-paclitaxel plus optional radiation, with the goal of finding a better second-line option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nab-paclitaxel (a chemotherapy drug) combined with local radiation therapy
- What this could lead to
- If it works, this could offer a new second-line treatment option for people with advanced small-cell lung cancer, potentially improving tumor control and survival.
- What could go wrong
- This is an early-phase, single-arm study with no comparison group, so results may not be definitive. The combination may cause side effects like bone marrow suppression, and not all patients may benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can donor immune cells boost lung cancer remission?
- Could adding chest radiation extend life in advanced lung cancer?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Can a new drug tame advanced solid tumors?
- Can a pill help keep advanced lung cancer at bay?
- Can a remote approach bring clinical trials to lung cancer patients?